News
General Intermediates Successfully Completes Government of Canada Funded Pharmaceutical Project
Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have successfully completed a research project related to a key starting API material for a global ...
General Intermediates Announces Ability to Produce Bio-Safe, Bio-Molecules for the Pharmaceutical Industry
Edmonton’s General Intermediates of Canada Inc. announced today that they have developed a unique process for making specialized bio-molecules for pharmaceutical fermenters, producing them in a certified, bio-safe manner. These ...
General Intermediates Reveals New Cyclization Technique for Production of Pharmaceuticals
Edmonton’s General Intermediates of Canada Inc. announced today that they have pioneered a process for simplifying the production of pharmaceuticals. “This proprietary synthesis methodology addresses the age old question faced by any ...
General Intermediates Announces Second Nucleoside Breakthrough
General Intermediates Canada announced today that they have the developed a second proprietary technique for nucleoside substitution. This technique applies to all nucleoside synthesis where unique or rare ...
General Intermediates Announces Nucleoside Breakthrough
General Intermediates Canada announced today that they have perfected work on the production of Ultra-Pure Nucleosides for use in the pharmaceutical and high-tech sensor industries. ...